Governing secondary research use of health data and specimens: the inequitable distribution of regulatory burden between federally funded and industry research
{{output}}
Some of the most promising recent advances in health research offer opportunities to improve diagnosis and therapy for millions of patients. They also require access to massive collections of health data and specimens. This need has generated an aggressive and... ...
